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Abstract The goal of the study was to determine the relation-
ship between in vitro/in vivo efficacy of environmental
Pseudomonas phages and certain phenotypical properties of
Pseudomonas aeruginosa (PA) strains. We studied the diver-
sity between particular isolates and determined phage sensi-
tivity in vitro and in vivo in the Galleria mellonella insect
model. Twenty-eight lytic bacteriophages specific for PAwere
tested against 121 CF PA isolates including 29 mucoid PA
strains. Most strains from cystic fibrosis (CF) patients were
lysed by at least three phages (93.6 %), but completely insen-
sitive strains were also present (6.4 %). Two phages PA5oct
and KT28 exhibited high rates of lytic potency on 55–68% of
PA strains (72–86 % of mucoid isolates). We further explored
phage activity against six PA strains (CF and non-CF) in vitro,
comparing clonal differences in phage susceptibility with bac-
terial properties such as the ability to form biofilms, mucosity,
twitching motility, and biochemical profiles. We observed the
relationship between variation in phage susceptibility and
Fourier transform infrared spectroscopy (FTIR) analysis in
the spectra window of carbohydrates. The protective efficacy
of two selected phages against PA PAO1 and 0038 infection
was confirmed in vivo in G. mellonella larvae. Generally, the
wax moth model results confirmed the data from in vitro as-
says, but in massive infection of CF isolates, the application of
lytic phages probably led to the release of toxic compound
causing an increase in larvae mortality. We assumed that apart
of in vitro phage activity testing, a simple and convenient wax
moth larvae model should be applied for the evaluation of
in vivo effectiveness of particular phage preparations.
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Introduction
Pseudomonas aeruginosa (PA) is the key pathogen associated
with lower respiratory tract illness in patients with cystic fi-
brosis (CF), infecting up to 80 % of adult patients. Once
established, the pathogen is difficult to eradicate (Davies
2002; Parkins et al. 2012). Increased viscosity of mucus asso-
ciated with the CF-lung causes favorable conditions for per-
sistent infection by opportunistic bacteria. Chronic infection
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and associated inflammatory responses lead to progressive
loss of lung function and respiratory failure (Callaghan and
McClean 2012; Costello et al. 2011). Antibiotic therapy is
usually effective only in the early stages of infection. During
the development of a chronic infection, even long-term anti-
biotic therapy with high doses does not result in eradication of
the pathogen. This is multifactorial (Bradbury et al. 2008;
Cheng et al. 1996; Fothergill et al. 2012). Bacterial adaptation
is a characteristic of CF-related PA strains. Alterations in fea-
tures such as antibiotic resistance, adhesion, alginate, and mu-
cus production are common and can affect the success of
clinical treatment (Silbert et al. 2001). Moreover, the strains
of PA isolated in the late stages of infection are very hetero-
geneous and demonstrate microevolution within an individual
strain with a characterized genetic profile. This phenotypic
variability of strains underlies the frequent failure of antibiotic
therapy and also creates a problem for the development of
alternative treatments (Bragonzi et al. 2009; Cramer et al.
2011). Multidrug resistance and biofilm formation are addi-
tional problems associated with the treatment of P. aeruginosa
infection, implying that alternative treatment methods are
needed for eradication or suppression of PA. Lytic bacterio-
phages offer a potentially exciting alternative approach in
treatment for PA infections. Nevertheless, phage therapy, es-
pecially in the eradication of PA clones from CF patients,
requires extensive preclinical testing of phage biology and
antibacterial activity.
In this study, we were interested in the relationship between
in vitro/in vivo efficacy of environmental Pseudomonas
phages and certain phenotypical properties of selected strains.
Therefore, we first selected two phages with the broadest
spectrum and analyzed them against six isolates that were
examined for mucoid slime production, twitching motility,
biofilm-forming ability and biochemical composition variabil-
ity as analyzed by Fourier transform infrared spectroscopy
(FTIR) techniques. Phage lytic activity was tested both
in vitro and in vivo using the Galleria mellonella larvae mod-
el. The most active phages were characterized by electron
microscopy and genome size.
Materials and methods
Bacterial strains
Eighteen PA strains were used as hosts for phage propaga-
tion: PAO1 (ATCC 15692) purchased from the American
Type Culture Collection (ATCC); two clinical CF PA strains
(isolated from a CF patient) from the collection of the
Prague CF Centre, Czech Republic; one clinical CF PA
strain (isolated from the lung infection of a CF patient) from
the collection of Newcastle University Medical School,
Newcastle upon Tyne, UK; and 14 clinical non-CF PA
strains (isolated from patients without CF) from the collec-
tion of the Institute of Genetics and Microbiology,
University of Wroclaw, Poland. A total of 123 PA isolates
were used for phage lytic potency: namely PAO1; 121 clin-
ical CF PA isolates from the collection of the Prague CF
Centre; and non-CF0038 clinical PA strain from the collec-
tion of the Institute of Genetics and Microbiology,
University of Wroclaw, Poland.
Bacteria were stored at −70 °C in tryptic soy broth (TSB;
Becton Dickinson and Company, Cockeysville, MD) supple-
mented with 20 % glycerol.
Phage isolation
Six water samples collected from a natural wastewater
treatment plant (irrigated fields) located in Wroclaw,
Poland, as phage sources were centrifuged at 15,000g
for 15 min, and the supernatants were filtered through a
0.22-μm Millex-GP filter (Merck Millipore, Darmstadt,
Germany, SLGP033RS). One milliliter of filtered water
sample and 0.5 ml of a bacterial broth culture, grown
overnight in TSB, were added to 10 ml of TSB and incu-
bated at 37 °C for 18 h. The suspension was then centri-
fuged again, treated with chloroform, and filtered through
a 0.22-μm Millex-GP filter (Merck KGaA, Darmstadt,
Germany). This procedure was repeated three times to
eliminate any bactericidal activity by contaminating
chemicals. Bacteriophage presence and titer in the filtrate
were assessed by the plaques test using the double-agar
layer technique (Adams 1959). Phages were propagated
from a single plaque. The phage lysate was then subjected
to PEG 8000 (Acros Organics, Geel, Belgium) precipita-
tion. The 28 environmental bacteriophages lytic on PA
strains (27 named KT and one phage PA5oct) were depos-
ited in the phage collection of the Institute of Genetics
and Microbiology, University of Wroclaw, Poland.
Phage lytic potency
Prior to phage sensitivity testing bacteria were subcultured in
TSB. Unless stated otherwise, bacteria were grown for 4–6 h.
To determine bacterial susceptibility to phage-mediated lysis,
bacteria grown on liquid TSB medium at 37 °C were trans-
ferred directly onto TSA plates. After drying, a drop of the
phage suspension (108 PFU ml−1) was put on the bacterial
layer and incubated at 37 °C. The plates were checked after
4–6 h and again 18 h later for the presence of bacterial lysis.
The phage lytic potency assay was repeated at least three
times. Spot testing is a rapid and efficient method for deter-
mining the host range in a large collection of bacteria (Adams
1959; Kutter 2009).
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Electron microscopy
The filtered high-titer phage lysate was centrifuged at 25,000g
for 60min, using a Beckman (Palo Alto, CA) J2-21 centrifuge
and a JA19.1 fixed-angle rotor. The pellets were washed two
times in ammonium acetate (0.1 M, pH 7.0) under the same
conditions. Phages were deposited on copper grids with
carbon-coated Formvar films (Agar Scientific, Elektron
Technology UK Ltd, Stansted, UK) and stained for 10 s with
uranyl acetate (2 %, pH 4.5) or phosphotungstate (2 %, pH 7).
Excess liquid was blotted off, and phages were examined
under a Philips EM 300 electron microscope. Magnification
was controlled bymeans of T4 phage tails (Ackermann 2009).
Pulsed field gel electrophoresis analysis
Pulsed field gel electrophoresis (PFGE) analysis was per-
formed by previously described method (Drulis-Kawa et al.
2014). Prepared blocks were placed in lysis buffer (50 mM
Tris, 50 mM EDTA, 1 % SDS) and digested for 2 h with
100-μg ml−1 proteinase K solution at 54 °C. After digestion,
plugs were rinsed four times with TE buffer. DNA samples
were placed on a 1 % agarose gel using the Bio-Rad
(Hercules, CA, USA) CHEF-DR III system (16.5 h,
6 V cm−1, 12 °C, switch time 1–50, angle 120°). Low
Range PFG Marker (New England Biolabs, Ipswich, MA,
USA, N0345S) was used as a size marker.
Subsurface twitching assay
The subsurface twitching assay was performed as previously
described by Semmler et al. (1999) with a slight modification.
Ten P. aeruginosa colonies taken randomly were tested for
twitching motility. Each colony was stab-inoculated through
the agar to the underlying Petri dish and incubated at 37 °C for
48 h. The zone of motility at the agar Petri dish interface was
measured after 0.01 % crystal violet (CV) staining.
Biofilm quantification by crystal violet assay on peg lid plates
The biofilm formation by P. aeruginosa strains was measured
by O’Toole and Kolter standard biomass assays using crystal
violet (CV) with modifications (Aaron et al. 2002; O’Toole
and Kolter 1998; Waszczuk et al. 2012). For the experiments,
overnight cultures of bacterial strains were suspended in a
physiological saline and diluted to an optical density of 0.5
McFarland units. The culture was then serially diluted in TSB
medium to obtain a final density of 5×105 colony-forming
units (CFU) ml−1. Two hundred microliters of prepared sus-
pension was added into each well of a round-bottomed poly-
styrene 96-well microtiter peg lid plate. The plates were then
incubated for 24 h at 37 °C. After 24 h of incubation the peg
lid was transferred to new titer plate and washed two times
(nonadhered cells were removed from each peg, and lids were
rinsed using 200 μl of physiological saline). The peg lids were
submerged into 200 μl of 0.01% CV solution (Sigma-Aldrich
Chemie GmbH, Steinheim, Germany) added to each well. The
excess CV was removed, and bound CV was released by
adding 200 μl of 96 % ethanol (Sigma-Aldrich Chemie
GmbH, Steinheim, Germany). The absorbance was measured
at 595 nm using a multilabel microtiter plate reader (UVM
340, AsysHitech, Eugendorf, Austria). The positive control
consisted of 100 μl of 0.01 % CV solution, while the negative
control was 96 % ethanol. All assays were repeated 24 times
per strain.
Attenuated total reflectance–Fourier transform infrared
spectroscopy
FTIR is a scientific technique based on measurement of vibra-
tional energy changes of organic compounds excited by IR
radiation. Due to the fact that vibrational energy is quantized,
the frequencies of various functional groups can be detected
only at fixed wavelengths, specific for every molecular com-
pound. Vibrational spectra typical for biological samples in
most cases correspond to mid-IR (4000–400 cm−1), and there
are five spectral windows defined within that spectrum
(Alvarez-Ordóñez et al. 2011). For minimal interference with
the test material, in this study, the IR spectrum measurement
was conducted by attenuated total reflectance (ATR)-FTIR.
The IR spectral range was limited to 4000–900 cm−1, and four
spectral windows were taken into account. Every windowwas
specific for one group of organic compounds, i.e., carbohy-
drates (1200–900 cm−1), carboxylic groups (1500–
1200 cm−1), proteins (1700–1500 cm−1), and lipid compounds
(3000–2800 cm−1) (Alvarez-Ordóñez et al. 2011).
Experimental procedure
The biochemical profile of bacterial samples was measured by
ATR-FTIR spectroscopy (Spotlight 400 FTIR Imaging
System, Perkin Elmer, Waltham, MA, USA). Sample prepa-
ration procedures for ATR include direct transfer of ten single
bacterial colonies to the crystal, separately. The spectra were
collected at room temperature over the wave space number
range of 4000 to 900 cm−1 with a resolution of 4 cm−1, and
50 repeats were averaged to improve the signal to noise ratio.
The spectra were displayed in terms of absorbance, which was
calculated using Perkin Elmer software. A background mea-
surement of the crystal was taken before each sample was
applied. The spectrum obtained for each clone was analyzed
in definite ranges, allowing to estimate the variability of spe-
cific groups of biochemical components. The range 1200–
900 cm−1 is typical for carbohydrates, range 1500–
1200 cm−1 corresponds to the carboxyl groups, the range of
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1700–1500 cm−1 is characteristic of proteins and within the
3000–2800 cm−1 the lipid fraction can be analyzed.
Pretreatment of spectra
The preprocessing was done as follows: baseline correction in
the range of 2404 to 2275 cm−1 and smoothing of the spectral
region from 2725 to 1556 cm−1 were done. The spectra were
normalized such that the smallest recorded absorbance was set
to 0 and the highest was set to 1 for each spectrum and then the
first derivatives (Savitzky and Golay) with a window of 5
were used for chemometrics. The derivation of the spectra to
the second order was used to increase the number of discrim-
inant features present in the spectra.
Chemometric analysis
Reproducibility and discriminatory power were calculated for
the working spectrum (range 4000–900 cm−1) and, indepen-
dently, for the particular sections according to the important
regions of infrared spectroscopy. To measure the degree of
similarity between ten replicates (ten colonies), we used the
differentiation index D expressed asD=(1−r)×1000, where r
indicates the Pearson correlation coefficient (Mouwen et al.
2005). Smaller D values indicate more similar colonies (for
identical strains, D=0). All statistical computations were car-
ried out using the program R version 2.15.1 (R Core Team
2012) (http://www.r-project.org/).
Galleria mellonella larvae model
The in vivo assay was conducted on a wax moth larvae model
(G.mellonella, Livefoods Direct, Sheffield, UK). Prior to each
experiment the larvae were subjected to a 7-day acclimatiza-
tion period in the dark at 15 °C. Experiments were performed
in triplicate (ten larvae per trial). For survival control, we
observed both untouched larvae and larvae injected with
20 μl of sterile saline buffer. Depending on the growth rate
of the tested bacterial strains, experiments were conducted up
to 96 h. Freshly plated bacterial cultures were inoculated into
Luria Broth (LB, Sigma-Aldrich) tubes and incubated at 37 °C
overnight under agitation. After 18 h, the bacterial suspension
was diluted with physiological saline to OD600=0.1 and this
was used as a starting point for serial dilutions. For the mea-
surement of P. aeruginosa virulence, 10 μl of diluted bacterial
suspension (serially diluted to 10−8 CFU) were used to infect
larvae. Both bacteria and bacteriophages were administered to
larvae by injection into the ventral side of the last pair of
pseudopods. After injection, the larvae were incubated for
72 h at 37 °C. The effects of infection were checked at 8,
24, 48, 72, and 96 h after injection by assessment of survival
and macroscopic appearance. For assessment of the antibac-
terial activity of selected phages, larvae were injected with
10 μl of bacterial suspension and, within 1 h, 10 μl of phage
lysate at the titration equal to multiplicity of infection (MOI)
100. Each experiment was carried out for 72 h at 37 °C, and
results were read at 8, 24, 48, and 72 h. The results were
expressed as the percentage survival rates. The experiments
were performed at least three separate occasions. The experi-
ments were controlled by observation of uninfected larvae,
sham-infected larvae, larvae receiving phage lysate only, and
infected but phage untreated larvae.
Statistical analysis
The analysis of survival curves was performer by log-rank
Mantel-Cox test. p Values <0.05 were considered statistically
significant. Statistical analysis was performed using GraphPad
Prism software (GraphPad Software, Inc., La Jolla, USA).
Results
Phage characteristics
The lytic potency of the phage collection (28) specific for PA
was performed against 121 CF isolates including 29 mucoid
strains. All strains used had been previously characterized by
genotyping methods such as multilocus sequence typing
(MLST) and random amplification of polymorphic DNA
(RAPD). Only unique clones were selected for this study
(Maiden et al. 1998). In the phage lytic potency experiments
(Fig. 1), several phages exhibited high antibacterial lytic po-
tency, with 55 % (phage PA5oct) and 68 % isolates (phage
KT28) in total and 72 and 86 % of mucoid isolates showing
potency, respectively. Completely insensitive PA were also
present (6.4 %). The CF PA strains showed strong heteroge-
neity in phage susceptibility presented as confluent clear lysis,
confluent opaque lysis, and single resistant colonies on
plaque. Disparate results in three consecutive experiments
may suggest the existence of multiple clones within each CF
isolate. We have also analyzed isolates, classified to particular
RAPD cluster, cultured form one patient at different time of
infection. Seventy-one isolates from 31 patients (31 strains
total) were typed to evaluate the changes in phage patterns.
It turned out that during the colonizing process, 21 strains did
not change their susceptibilities to the phage collection, 8
strains lost their ability to propagate phages, and 8 strains
become susceptible to more bacteriophages from the
collection.
The two phages with the strongest lytic activity (PA5oct
and KT28) were examined by transmission electron micros-
copy and classified on the basis of their morphological fea-
tures in the order Caudovirales and the family Myoviridae
(Fig. 2). Phage KT28 is PB1-like viruses with an approximate
head diameter of 70 nm between opposite apices and tails of
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113×17 nm, a base plate, and fibers of 40 nm in length
(Ceyssens et al. 2009). Phage PA5oct is a giant unclassified
myovirus with an isometric head of about 131 nm in diameter
and a contractile tail about 136 nm long (Drulis-Kawa et al.
2014). The isolates were named according to a recent nomen-
clature system as vB_PaeM_PA5oct and vB_PaeM_KT28
(Kropinski et al. 2009). The phages’ genome size was deter-
mined by PFGE (Fig. 3). KT28 DNAs were about 70 kbp in
size, whereas that of PA5oct was approximately 375 kbp
(Drulis-Kawa et al. 2014).
To explore possible variation in phage susceptibility within
a given strain, six PA isolates were chosen: PAO1 as a refer-
ence strain; non-CF0038, a clinical strain isolated from a
wound infection; CF217 (unique cluster, small colony, early
infection); CF708 (cluster 1, small colony, slow growth, late
infection), and two sequential isolates CF532 nonmucoid and
CF832 mucoid from one CF patient (Table 1). The variability
of phage lytic activity examined in four bacterial culture pas-
sages is illustrated in Fig. 4. Reference PAO1, the non-CF
strain, and the paired isolate CF532 exhibited almost
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Fig. 1 In vitro susceptibility of 123 P. aeruginosa strains to the collection of environmental Pseudomonas phages. Phage-mediated lysis was performed
by spot technique on TSA plates at 37 °C by application of 108-PFU/ml phage suspension. The assay was repeated at least three times
Fig. 2 Electron micrograph of
PA5oct phage (a) and KT28
phage (b) negatively stained with
uranyl acetate. The bar indicates
100 nm
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homogeneous sensitivity to phages whereas CF217, CF708,
and CF832 isolates showed clonal diversity during four pas-
sages of the phage treatment assay. The PAO1 and CF532
were fully sensitive to both phages, giving confluent clear
lysis in almost all passages. The non-CF isolate (0038) was
also susceptible to phage lysis, but in the case of PA5oct ap-
plication, single resistant colonies were detected in the plaque
zone. The CF708 and CF832were generally susceptible to the
chosen phages but exhibited various profiles during four pas-
sages of treatment, which suggested strong clonal diversity.
The CF217 isolate was almost totally resistant to the applied
phages, although phage PA5oct and KT28 gave a slightly
inhibitory effect on bacterial growth. The application of a
phage cocktail composed of both tested viruses showed ho-
mogeneous confluent clear lysis in all four passages (PAO1,
non-CF0038, CF708, CF532, CF832), suggesting an additive
effect of the phage mixture. No activity of the cocktail was
observed for PA CF217.
PA strains diversity
The high morphological diversity among PA strains influenc-
ing variation in phage susceptibility was further tested by the
following features: (i) mucoidy, (ii) production of specific
type IV pili–twitching motility, (iii) biofilm-forming ability,
and (iv) biochemical composition fluctuation measured by
ATR-FTIR spectroscopy. Bacterial morphology diversity tests
(i–iii) are presented in Table 1. Five strains were similarly
immutable in their lack of mucoidy, withmucoid CF832 being
the exception. There was no significant clonal diversity
among particular isolates in type IV pilus-dependent motility.
The non-CF0038 and CF217 PA isolates exhibited a high de-
gree of twitching motility with zone diameters reaching 30.4±
2.5 and 17.2±1.6 mm, respectively, within 48 h. The lowest
value of motility was presented by PA CF708, suggesting lack
of type IV pili. The third examined feature was the ability of
biofilm formation which ranged from an OD of 0.04 (CF832)
up to OD 1.92 (CF217). Testing 24 randomly taken PA colo-
nies revealed the strongest clone diversity in biofilm forma-
tion of PA CF217, which showed a range of OD from 1.36 to
2.48.
The total chemical profile of bacterial samples was mea-
sured byATR-FTIR spectroscopy over the wavenumber range
of 4000 to 900 cm−1 (Fig. 5). The vibrations assigned to lipids
were around 3000–2800 cm−1 (window 1) (Winder and
Goodacre 2004); the bands around 1700–1500 cm−1 (window
2) derived from proteins and the region from 1450 to
1200 cm−1 (window 3) was mainly due to the carboxylic
groups of proteins, free amino acids, and polysaccharides
wherein wavenumber 1250–1200 cm−1 is characteristic for
the phosphate stretching mode due to the nucleic acids and
phospholipids (San-Blas et al. 2012; Winder and Goodacre
2004). In addition to proteins, lipids, and nucleic acids, carbo-
hydrates are also present, with a typical region of 1200–
900 cm−1 wavenumber (window 4). For the analyzed strains,
the reproducibility of the typing method and the clonal diver-
sity of the bacterial strains were examined based on the mean
value of D indexes evaluated for all pairs of spectra within a
given strain. Reproducibility was measured for the five work-
ing ranges (windows 1, 2, 3, 4, and total 4000–900 cm−1
wavenumber) (Table 2). The total D value among tested
strains was relatively low (0.9–4.2), except paired isolates
(21.7–24.5). The highest phenotypic clonal variations were
noted for the non-CF0038 strain in the lipid window (145.9)
and for mucoid strains in the carbohydrates and carboxylic
Table 1 Morphological diversity of selected sixPA strains tested by the
following features: mucoidy, production of specific type IV pili–
twitching motility, and biofilm-forming ability, as the elements consid-
ered in term of phage susceptibility variation
Strain Mucoidy Twitching motility zone
diameter (mm)
Biofilm formation
OD (590 nm)
PAO1 Negative
(stable)
4.6±0.7 1.14±0.23
Non-CF0038 Negative
(stable)
30.4±2.5 0.67±0.1
CF217 Negative
(stable)
17.2±1.6 1.92±0.56
CF708 Negative
(stable)
1.45±0.9 0.15±0.04
CF532 Negative
(stable)
3.8±0.6 0.28±0.09
CF832 Positive
(stable)
2.9±0.7 0.04±0.02
Fig. 3 Pulsed field gel electrophoresis analysis of PA5oct phage DNA
and KT28 phage DNA. Low Range PFG Marker (LMR) was used as a
size marker
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groups spectra (D=70.9 and D=72.8). The most homoge-
neous culture was the laboratory PAO1 strain, with the D
value varying from 0.9 to 14.7 in four window spectra.
Variability of the D value strongly depends on the standardi-
zation of sample preparation procedures, spectral data acqui-
sition parameters, medium preparation, growth temperature,
incubation time, sample preparation, and spectrum measure-
ment; thus, the appropriate spectral normalization should be
included according to Naumann (2000), where meanD values
up to 10 are considered as standard when analyzing the sam-
ples prepared from independently grown cultures and all spec-
tral ranges are analyzed. The obtained results indicated that
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bacteriophages during four
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Fig. 5 The total chemical profile
of six PA strains measured by
ATR-FTIR spectroscopy over the
wavenumber range of 4000 to
900 cm−1. Ten single bacterial
colonies were tested separately
for each strain, and 50 repeats of
spectra were collected and
averaged to improve the signal to
noise ratio
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the crucial differences in colony chemical profile were found
in two regions: 3000–2800 cm−1 (window 1) and 1200–
900 cm−1 (window 5) for lipids and carbohydrates, respective-
ly (Table 2). We observed that the variation in phage suscep-
tibility in vitro, measured in four passages treatment, was not
related with high D values.
In vivo efficacy of phage treatment
To verify the in vitro efficacy of two phages in relation to PA
strains diversity, the following experiments were done in vivo
on the wax moth larvae model. Prior to the appropriate exper-
iments, the virulence of six chosen PA strains was determined.
P. aeruginosa is highly virulent in this model, being their
natural pathogen; thus, the lethal doses are very low. The
wax moth larvae were injected with serial bacterial inocula
(from 10 to 108 CFU) and incubated for 4 days. The caterpillar
mortality rate was checked at 8, 24, 48, and 72 h after infection
(Table 3). The experiments were controlled by a group of
uninfected larvae and a group of larvae that received a control
injection of saline where a 100% survival rate was obtained in
both groups. We found that PAO1, non-CF0038, and CF217
PA isolates were lethal even at the dose of 10 CFU where over
90 % larvae mortality was noted after 1 day of infection. The
CF532, CF832, and CF708 isolates were significantly less
virulent in comparison to the most virulent PAO1
(p<0.0001) and even at very high concentrations as
105 CFU dose the delay of killing was observed (100, 90,
and 40 % of infected larvae, respectively, after 3 days of in-
fection). These isolates exhibited lower virulence reflected by
delay in larvae killing and a slow rate of growth. The lethal
doses of 10 CFU for PAO1, non-CF0038 and CF217, and
105 CFU for the remaining strains were chosen for further
experiments.
The phage treatment results were observed at 8, 24, 48, and
72 h after injection (Fig. 6). All experiments were controlled
by observation of uninfected larvae, sham-infected larvae, lar-
vae receiving phage lysate only (100 % of larvae survival),
and infected but phage untreated larvae. To determine whether
the effects of phage therapy were associated with a nonspecif-
ic immune activation response, UV-inactivated phages at the
same inoculum were used to assess their ability to rescue
infected larvae. The efficacy of UV inactivation was assessed
if no viable phage was detected by in vitro plating. The
inactivated phages were used to treat larvae infected with a
lethal dose of PA strains, and no differences in larvae mortality
were noted in comparison to control infected caterpillars. This
confirmed that larval survival was entirely due to phage lytic
activity rather than to host immune stimulation.
The phage application showed a significant impact on
Galleria larval rescue from lethal infection (Fig. 6). Phage
KT28 was the most potent whereas PA5oct was the least ef-
fective preparation considering both non-CF Pseudomonas
strains (p<0.0001). The antibacterial activity of the former
against non-CF strains showed rescuing around 20% of larvae
even 2 days after lethal dose application. Moreover, KT28
Table 2 Differentiation index for analyzing biochemical clonal variations within given P. aeruginosa strains
Strain 4000–900 cm−1
Total spectrum
1200–900 cm−1
Window 4 (carbohydrates)
1500–1200 cm−1
Window 3 (carboxylic groups)
1700–1500 cm−1
Window 2 (proteins)
3000–2800 cm−1
Window 1 (lipids)
PAO1 0.9 7.6 6.4 0.3 14.7
Non-CF0038 3.0 17.8 9.1 1.0 145.9
CF217 1.4 9.9 7.7 1.0 27.8
CF708 4.2 32.2 16.1 3.7 23.5
CF532 21.7 36.4 52.9 10.1 111.2
CF832 24.5 70.9 72.8 9.2 90.1
The appropriate spectral normalization according to Naumann (2000) consider D values up to 10 as standard. Variability of the D value (above 10) are
italicized
Table 3 The virulence of PA strains tested in Galleria model
PA01 (10 CFU) Non-CF0038 (10 CFU) CF217 (10 CFU) CF708 (105 CFU) CF532 (105 CFU) CF832 (105 CFU)
8 h 80 % 90 % 77 % 100 % 100 % 100 %
24 h 0 % 10 % 6 % 100 % 90 % 100 %
48 h 0 % 0 % 0 % 90 % 40 % 40 %
72 h 0 % 0 % 0 % 60 % 0 % 10 %
96 h 0 % 0 % 0 % 40 % 0 % 0 %
Survival of infected larvae was followed over a period of 4 days. Three independent experiments containing ten larvae per each were pooled. The
caterpillar survival rate is presented as a percentage in comparison to 100 % survival rate of uninfected larvae
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preparation was also more effective against CF708 in compar-
ison to PA5oct (p<0.07). The application of single preparation
of KT28 or PA5oct to cure infection of phage resistant strain
CF217 was not effective, whereas a mixture of both lysates in
the final MOI 100 increased the survival rate of Galleria
initially infected with CF217 by up to 30 and 20 % at 24
and 48 h, respectively (Fig. 6). However, the protective activ-
ity of the phage cocktail against noncystic fibrosis
Pseudomonas infection in larvae was lower than for single
phage application (p<0.05 for mix vs PA5oct against PAO1,
Fig. 6 Antibacterial activity of phages (MOI 100) in the treatment of
infected Galleria larvae by PA strains. Survival of infected larvae was
followed over a period of 3 days. Three independent experiments
containing ten larvae per each were pooled. Statistical analysis was
calculated for pairwise comparisons between infected larvae and phage-
treated infected larvae using Mantel-Cox test
Appl Microbiol Biotechnol (2015) 99:6021–6033 6029
p<0.0001 for mix vs KT28 against PAO1 and NS for mix vs
PA5oct against non-CF0038, p<0.0001 for mix vs KT28
against non-CF0038).
Unexpected results were obtained for weakly virulent CF
isolates (CF708, CF532, CF832). The chosen lethal dose for
these isolates was much higher than for previous strains (105
vs 10 CFU); thus, the phage inoculum was also higher to keep
MOI value of 100. The application of phage preparation both
as single virus or cocktail did not protect larvae from death
with one exception (action of KT28 on CF708). The possible
explanation of such phenomenon could be the release of toxic
compound during massive bacterial cell lysis after phage
propagation, which may cause an increase in larvae mortality
in comparison to not treated caterpillars.
Discussion
Recently, phages and phage-encoded proteins have been pro-
posed as natural food preservatives and antimicrobial agents
to fight bacterial infections in humans, animals, or crops of
agricultural importance (Drulis-Kawa et al. 2012; Glonti et al.
2010). Phage therapy is promising in the eradication of drug-
resistant pathogens such as bacteria-colonizing patients suffer-
ing from cystic fibrosis (Alemayehu et al. 2012; Carmody
et al. 2010; Debarbieux et al. 2010; Essoh et al. 2013;
Morello et al. 2011). Recent reports of curative and preventive
bacteriophage treatments in a mouse lung infection model,
where lytic phages were administered in one single dose, suc-
cessfully rescued mice from lethal infections caused by
Burkholderia cenocepacia (Carmody et al. 2010) and
P. aeruginosa (Morello et al. 2011). Special interest is focused
on P. aeruginosa infections because of strong clonal diversity
of these bacteria which can result in treatment issues. For these
reasons, the application of lytic phages was tested in this study
on selected PA isolates to determine their efficacy in vitro and
in vivo in comparison to bacterial diversity of particular bio-
logical features such as mucoidy, twitching motility, the inten-
sity of biofilm formation, and biochemical composition.
Although strong heterogeneity connected with in vitro phage
susceptibility was noted, two myovirus phages with a broad
spectrum of activity were selected among 28 environmental
phages. The KT28 phage was classified as PB1-like viruses
and a novel giant phage PA5oct belonged to the family
Myoviridae (Drulis-Kawa et al. 2014).
The phenotypical diversity among PA strains may influence
the variation in phage susceptibility by modifying, masking,
or replacing phage receptors required in the first virion-
bacterial interactions during viral infection (Abedon 2006;
Drulis-Kawa et al. 2012; Guttman et al. 2005; Hanlon 2007;
Leclerc et al. 2000; Lenski 1988; Matsuzaki et al. 2005;
Young and Wang 2006). Phages can recognize surface com-
ponents of a bacterial cell including lipopolysaccharide (LPS),
peptidoglycan, teichoic acids, outer membrane proteins, oli-
gosaccharides, capsule, and type IV fimbriae for the adhesion
process (Abedon 2006; Drulis-Kawa et al. 2012; Guttman
et al. 2005; Hanlon 2007; Leclerc et al. 2000; Lenski 1988;
Matsuzaki et al. 2005; Young andWang 2006). The specificity
of interaction between phage attachment structures and host
cell surface receptors mostly influences the bacterial host
range (Drulis-Kawa et al. 2012; Sulakvelidze et al. 2001;
Weinbauer 2004). Our previous work done on PAO1 mutants
(paper in preparation) allowed the determination of the bacte-
rial receptor recognized by KT28 phage (LPS elements) and
PA5oct phage (type IV fimbriae and probably LPS as well).
Examining our selected PA isolates, we conclude that the
PAO1 strain, as the most susceptible to tested phages, was
also clonally homogeneous in biochemical analysis done by
FTIR and did not produce biofilm intensively. Therefore, this
type of host seems to be the best target for effective phage
attack. The non-CF PA strain (0038) exhibited strong
twitching motility and low activity of biofilm formation.
Although this strain showed strong clonal variation in lipid
composition, the in vitro susceptibility to phages was relative-
ly homogeneous. Lipid composition should have no signifi-
cant influence on the first step of viral infection, adhesion,
because phages usually utilize carbohydrate or protein as re-
ceptors (Abedon 2006; Drulis-Kawa et al. 2012; Guttman
et al. 2005; Hanlon 2007; Leclerc et al. 2000; Lenski 1988;
Matsuzaki et al. 2005; Young and Wang 2006).
Phage lytic activity tested in vitro in the classical agar
method was compared with the Galleria mellonella larvae
in vivo model. This model is a very easy and convenient tool
for bacterial virulence determination. Some P. aeruginosa
strains are highly pathogenic in insects, such as
G. mellonella (Fancello et al. 2011; Miriagou et al. 2010)
and D. melanogaster (Barrow and Soothill 1997), when inoc-
ulated directly into the hemolymph. In our study, the results
obtained with the G. mellonella model generally correlated
with data obtained from in vitro assays, but only for non-CF
strains. The increased larval survival rates in the presence of
PB1-like phage, compared to the giant PA5oct, could suggest
the importance of phage size and phage generation time rate
(KT28<PA5oct) in the therapeutic results. This needs to be
further examined with a range of giant phage isolates. An
unexpected feature was seen in the application of phage cock-
tails. The mixture was less effective in the lysis of phage
susceptible PA strains PAO1 and non-CF0038 in comparison
to single lytic phage administration. A possible explanation
for such phenomenon could be the competition between
attacking virions for the adhesion receptors on bacterial cells.
If the receptors on PA surface used by phages are present in a
high number and are the same, similar, or located in close
vicinity with each other, the effective adhesion of particular
virions may be hampered or impaired. This would suggest that
phages selected for cocktail preparations should be designed
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to target different receptors enhancing the host range and al-
low synergistic activity of phages. Although standardized
methods to generate phage cocktails have been proposed
(Drulis-Kawa et al. 2012; Merabishvili et al. 2009), no clear
official guidelines exist to date (Drulis-Kawa et al. 2012;
Pirnay et al. 2011).
The results obtain for CF isolates in this study were more
complicated. The CF217 isolate with the growth rate similar
to PAO1 strain was almost totally resistant to in vitro admin-
istered phages although it produced type IV pili as a potential
phage receptor for PA5oct phage. Additionally, the culture
exhibited relatively high levels of biofilm production, which
might be helpful in the protection against viral invasion. In
contrast, in the in vivo study, the cocktail was more efficient in
the protection of larvae against PA CF217 infection than the
application of individual phage, implying an additive effect of
mixed preparation in the case of resistant strains (p<0.0001
for mix vs PA5oct against CF217, p<0.0001 for mix vs KT28
against CF217). The strong clonal diversity and loss of viru-
lence of CF-associated PA isolates is well known, and our
investigation confirms this statement. Slow growth rate, re-
duced twitching motility, low ability to biofilm formation,
and finally strong clonal diversity in the chemical profile of
the three tested CF isolates (CF708, CF532, and CF832) sig-
nificantly influenced the phage efficacy both in vitro and
in vivo. The CF708 strain and paired CF532/CF832 isolates
were variable in terms of clone carbohydrate and carboxylic
group composition, which influenced large differences in
phage susceptibility among separate passages (confluent clear
and opaque lysis or single resistant colonies on plaque) for
CF708 and CF832. Generally, the variations in chemical com-
position of the culture measured by the FTIR method affected
phage efficacy. More complications were noticed in in vivo
assay where the application of phage preparation did not cure
larvae from infection but even worsened the caterpillar condi-
tion (p<0.05 for KT28 against CF708). We suspect that this
was due to the massive release of toxic compounds during
bacterial cell lysis causing a deterioration of animal health. It
is well known that rapid lysis of a big number of cells during
phage propagation and the release of LPS from Gram-
negative bacteria in a short period of time may cause serious
side effects on the host; however, similar effects may occur
during bactericidal antibiotic application, as well (Goodridge
2010). The administration of bacteriolytic agents of any kind
in the treatment of Pseudomonas infection may result in se-
vere consequences as systemic inflammatory response syn-
drome; thus, the therapy should be carefully selected.
Generally, the treatment success is strongly influenced by
heterogeneity of particular pathogens causing chronic infec-
tions. The use of lytic phages may lead to selective pressures
and drive the expression of undesirable bacterial virulence
factors, which must be carefully studied prior to any clinical
trials. Overall, the effectiveness of phage cocktails against PA
isolates is promising alternative but requires additional de-
tailed investigations. The simple animal models such as wax
moth larvae model could be a convenient tool to evaluate the
effectiveness of particular phage preparations against clinical
isolates in vivo. Future work will need to consider the effec-
tiveness of phages in mixed culture models replicating the
Bairway microbiome^ including widely available and well-
characterized PA strains from diverse sources.
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